Wall Street Journal, July 8, 2014. A U.S. Food and Drug Administration database that catalogs medical-device problems holds thousands of entries on a tool called a laparoscopic power morcellator, used since the 1990s.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Faster Approval of New Medical Products Heightens Uncertainty Over Risks
AAAS, July 7, 2014. As new drugs and medical devices make their way through the FDA’s approval process at an accelerated rate, research on their safety and efficacy is not always as rigorous as it should be, experts cautioned at a AAAS event.
Read More »Shooting Stars, Hot Flashes, and Feeling Sexy
The Huffington Post, June 3, 2014. Pink viagra and shooting stars are both subject to a very strong placebo effect, and in both cases that can make people very happy. But one is more dangerous than the other.
Read More »FDA OKs First-Ever DNA Alternative to Pap Smear
AP Health Writer, April 24, 2014. Federal health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer.
Read More »Letter to the Editor: “FDA’s Compassionate-Use Program Offers Early Access Without Compromising Drug Trials”
Washington Post, April 24, 2014. If the pharmaceutical company is willing, parents who are understandably desperate to help their children can utilize the FDA’s compassionate-use program, which allows a patient with a life-threatening disease to receive an unapproved drug from the company.
Read More »